Premium
Safety of paranasal sinus surgery in patients with cystic fibrosis
Author(s) -
Schulte Douglas L.,
Kasperbauer Jan L.
Publication year - 1998
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1097/00005537-199812000-00009
Subject(s) - medicine , paranasal sinuses , sinus (botany) , surgery , cystic fibrosis , sinusitis , rhinorrhea , paranasal sinus diseases , frontal sinus , complication , maxillary sinus , population , anesthesia , botany , environmental health , biology , genus
Objective: Document the safety of paranasal sinus surgery in cystic fibrosis patients and review the changing trends in paranasal sinus surgery in the cystic fibrosis population. Study Design: Retrospective review. Materials and Methods: Chart review of cystic fibrosis patients who underwent paranasal sinus surgery from 1955 to 1997. Results: Indications for surgery included chronic sinusitis, nasal obstruction, purulent rhinorrhea, head pain, and pyocele. Average duration of anesthesia was 2.1 hours. The complication rate from general anesthesia was zero. Excessive bleeding and significant hypoxia did not occur. Conclusions: Paranasal sinus surgery and general anesthesia can be safely performed in cystic fibrosis patients. The indications for paranasal sinus surgery are changing from symptomatic nasal obstruction to pre‐lung transplantation care. Today, treatment has evolved to include placement of sinus catheters for direct topical instillation of antibiotics and consideration of maxillary and frontal sinus obliteration.